Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
53
DTNOF Quote, Financials, Valuation and Earnings
Last price:
$1.26
Seasonality move
:
7.12%
Day range:
$1.26 - $1.26
52-week range:
$0.85 - $1.35
Dividend yield:
9.25%
P/E ratio:
12.40x
P/S ratio:
1.82x
P/B ratio:
1.15x
Volume:
--
Avg. volume:
--
1-year change:
23.14%
Market cap:
$1.2B
Revenue:
$666.8M
EPS (TTM):
-$0.04
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, DNO ASA has -- downside to fair value with a price target of -- per share.
DTNOF vs. S&P 500
-
Over the past 5 trading days, DNO ASA has underperformed the S&P 500 by -0.06% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
DNO ASA does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
DNO ASA has grown year-over-year revenues for 1 quarter straight. In the most recent quarter DNO ASA reported revenues of $187.6M.
Earnings Growth
-
DNO ASA earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter DNO ASA reported earnings per share of --.
Enterprise value:
1.2B
EV / Invested capital:
--
Price / LTM sales:
1.82x
EV / EBIT:
65.81x
EV / Revenue:
1.73x
PEG ratio (5yr expected):
0.16x
EV / Free cash flow:
-53.44x
Price / Operating cash flow:
26.86x
Enterprise value / EBITDA:
5.73x
Gross Profit (TTM):
$251.1M
Return On Assets:
-1.57%
Net Income Margin (TTM):
-7.07%
Return On Equity:
-4.09%
Return On Invested Capital:
-2.38%
Operating Margin:
13.01%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $1.3B | $581.2M | $671.7M | $182.6M | $187.6M | |
| Gross Profit | $835.9M | $213.8M | $251.1M | $75.2M | $66.5M | |
| Operating Income | $713.9M | $133.1M | $109.2M | $60.9M | $24.4M | |
| EBITDA | $568.6M | $312.4M | $203.2M | $123M | $90.8M | |
| Diluted EPS | $0.33 | -$0.06 | -$0.04 | $0.02 | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1B | $1.4B | $1.4B | $932.2M | $1.9B | |
| Total Assets | $2.8B | $3.1B | $2.7B | $2.5B | $3.7B | |
| Current Liabilities | $311.6M | $399.5M | $400.1M | $270.8M | $731.6M | |
| Total Liabilities | $1.9B | $1.9B | $1.4B | $1.3B | $2.6B | |
| Total Equity | $905.7M | $1.1B | $1.4B | $1.2B | $1.1B | |
| Total Debt | $936M | $858.9M | $555.7M | $427.9M | $1.4B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $915.9M | $181.9M | $408.9M | $94.2M | $90.1M | |
| Cash From Investing | -$391.4M | -$259.9M | -$413M | -$50.5M | -$109.3M | |
| Cash From Financing | -$456.2M | -$224.3M | $872.3M | -$154.9M | $594.2M | |
| Free Cash Flow | $548.8M | -$81.8M | -$21.8M | $39.9M | -$23.1M | |
DTNOF
Sector
Market Cap
$1.2B
$57.4M
Price % of 52-Week High
93.04%
65.99%
Dividend Yield
9.25%
0%
Shareholder Yield
6.48%
4.75%
1-Year Price Total Return
23.14%
-23.9%
Beta (5-Year)
0.577
0.655
Dividend yield:
9.25%
Annualized payout:
$0.10
Payout ratio:
-224.84%
Growth streak:
3 years
Technicals
8-day SMA
Sell
Level
$1.26
200-day SMA
Buy
Level
$1.10
Bollinger Bands (100)
Buy
Level
1.1 - 1.26
Chaikin Money Flow
Sell
Level
--
20-day SMA
Sell
Level
$1.26
Relative Strength Index (RSI14)
Buy
Level
85.29
ADX Line
Neutral
Level
Williams %R
Sell
Level
0
50-day SMA
Buy
Level
$1.22
MACD (12, 26)
Buy
Level
0.34
25-day Aroon Oscillator
Sell
Level
0
On Balance Volume
Neutral
Level
--
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.3232)
Sell
CA Score
(Annual)
Level (-0.6794)
Buy
Beneish M-Score
(Annual)
Level (-2.7297)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-0.4364)
Buy
Piotroski F Score
(Annual)
Level (4)
Sell
Quality Ratio Score
Level (2)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
DNO ASA is an oil and gas exploration and production company. A group of licenses are held for fields in Kurdistan, Yemen, United Kingdom, and Norway. Producing assets in Kurdistan generate the most revenue for the company. Petroleum products from Kurdistan fields are either sold locally or externally, with external shipments constituting the majority. The company holds working interests in both onshore and offshore fields and operates as either the sole operator or partner in many of its facilities.
Stock Forecast FAQ
In the current month, DTNOF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The DTNOF average analyst price target in the past 3 months is --.
-
Where Will DNO ASA Stock Be In 1 Year?
According to analysts, the consensus estimate is that DNO ASA share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About DNO ASA?
Analysts are divided on their view about DNO ASA share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that DNO ASA is a Sell and believe this share price will rise from its current level to --.
-
What Is DNO ASA's Price Target?
The price target for DNO ASA over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is DTNOF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for DNO ASA is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of DTNOF?
You can purchase shares of DNO ASA via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase DNO ASA shares.
-
What Is The DNO ASA Share Price Today?
DNO ASA was last trading at $1.26 per share. This represents the most recent stock quote for DNO ASA. Yesterday, DNO ASA closed at $1.26 per share.
-
How To Buy DNO ASA Stock Online?
In order to purchase DNO ASA stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
